Yahoo Finance April 10, 2023
PR Newswire

Bain & Company’s report shows the resilience of healthcare in a downturn, citing biopharma and life sciences, value-based care and AI as areas for investors to watch

BOSTON, April 10, 2023 /PRNewswire/ — Published today, Bain & Company’s 12th annual Global Healthcare Private Equity and M&A report reflects the continued resilience of the healthcare industry, with 2022 seeing near-record levels of healthcare dealmaking, in terms of both volume and value.

Despite a slowdown caused by macro-economic and geopolitical forces in the second half of the year, 2022 was still the second-best year on record for healthcare dealmaking, due in large part to the white-hot pace of investment at the start of the year. Total disclosed deal value reached nearly $90...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Investments, Mergers & Acquisitions / JV, Payment Models, Pharma, Pharma / Biotech, Survey / Study, Technology, Trends, Value Based
Concerns raised over Indiana hospital merger
Medtronic buys surgical instrument developer Fortimedix
Addus Taking a Cautious Approach to Hospice Deals
CHS to sell 2 hospitals to AdventHealth
Why the DOJ’s Lawsuit Against the UGH-Amedisys Merger May Not Go Anywhere

Share This Article